Detalles de la búsqueda
1.
Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure.
Antivir Ther
; 3(4): 203-7, 1998.
Artículo
en Inglés
| MEDLINE | ID: mdl-10682139
2.
Loss of antiviral effect owing to zidovudine and lamivudine double resistance in HIV-1-infected patients in an ongoing open-label trial.
Antivir Ther
; 2(1): 39-46, 1997 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-11322265
3.
Virological response in multidrug-experienced HIV-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine.
Antivir Ther
; 6(1): 41-6, 2001 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-11417760
4.
In vitro inhibition of HIV-1 by Met-SDF-1beta alone or in combination with antiretroviral drugs.
Antivir Ther
; 5(3): 199-204, 2000 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-11075940
5.
Lack of in vitro anti-gp160 antibody production is a correlate of nonprogression among HIV type 1-infected individuals.
AIDS Res Hum Retroviruses
; 14(15): 1341-3, 1998 Oct 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-9788675
6.
In vitro effects of continuous pressure with zidovudine (ZDV) and lamivudine on a ZDV-resistant HIV-1 isolate.
AIDS
; 11(11): 1406-10, 1997 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-9302459
7.
Effective inhibition of HIV-1 isolated from patients with acute primary HIV-1 infection by aminooxypentane-RANTES.
AIDS
; 13(9): 1144-5, 1999 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-10397549
8.
In vitro evolution of the human immunodeficiency virus type 1 gag-protease region and maintenance of reverse transcriptase resistance following prolonged drug exposure.
J Clin Microbiol
; 39(3): 1124-9, 2001 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-11230439
9.
Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: in vitro studies of mixed virus infections.
J Virol
; 74(19): 9328-32, 2000 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-10982382
10.
Susceptibility to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitors.
Antimicrob Agents Chemother
; 44(5): 1328-32, 2000 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-10770770
11.
Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine.
J Acquir Immune Defic Syndr
; 22(1): 101-3, 1999 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-10534153
Resultados
1 -
11
de 11
1
Próxima >
>>